AGP Executive Report
Last update: 6 hours agoRSV vaccine update: Clover Biopharmaceuticals says its Phase 2 results in older adults strengthen its RSV+hMPV (and RSV+hMPV+PIV3) combo vaccine candidates, with broad neutralizing responses and a favorable safety profile. Patient safety: A roundup flags rising concerns over fake medicines, misbranding, and recalls, raising questions about how quickly unsafe products are pulled before patients are exposed. Local child health: An 8-year-old was taken to Children’s National Hospital after being found unresponsive in a Brandywine, Md. swimming pool, with CPR started on scene. Medicare coverage risk: A new report warns that Medicare Advantage plan nonrenewal notices must arrive by Oct. 2, and forced disenrollment has surged in recent years—especially in some states. DC-area health workforce & economy: U.S. job data shows women drove nearly all August hiring, with implications for health-sector staffing and local labor markets.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
